Single Crystal Growth & Structure Determination top 10

Absolute Structure Determination

Single crystal growth and structure determination technology are the main methods to determine the absolute configuration of drug molecules and identify the crystal forms absolutely. The single crystal culture and analysis technology firstly obtain high-quality crystals through a variety of experimental single crystal growth methods. After the single crystal is obtained by growth, the single crystal structure and/or the absolute molecular configuration are analyzed after collecting data by single crystal X-ray diffraction or Micro ED.

 

Crystal Pharmatech has completed the growth and analysis of hundreds of drug compound single crystals. Our technology has been proven to achieve a high probability of success of more than 90%, which is much higher than the industrial standard of 50%.

 

Crystal Pharmatech has two in-house state-of-art single-crystal diffractometers for most viable chemical systems as well as crystallographic partners for challenging systems. We also have access to National Synchrotron Light Source IIBrookhaven National Laboratory when the single crystals (e.g. 1-20 μm) are too small using standard X-ray diffraction. For microcrystals or even nanocrystals that are the size of 100 nm to 1 μm, we will then apply MicroED method to determine the crystal structure.

 

Single Crystal X-ray Diffraction (SCXRD)

Fast detection speed:10-15 min for conventional sample

 

High sensitivity: as little as 10 μm crystal

 

Extensive experience: over 10 years and hundreds of structure identification experiences

 

MicroED

Suitable for the detection of microcrystalline samples (< 200nm)

 

Higher theoretical signal-to-noise ratio

 

Higher spatial resolution

 

Diffraction and imaging information can feed back at the same time

 

If you want to know more about crystallization development, crystallization optimization, crystal development process and crystal development methodology, please visit our website.

 

As a cdmo pharma company, we will do our best to meet all the needs of clients.

 

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author

Founded in 2010, Crystal Pharmatech has been providing the world-leading solid state research, and formulation CDMO services to global pharmaceutical companies. We use Molecule-Material-Medicine (MMM) approach to develop the best crystal and formulation for your molecules. Over the last 11 years, we have supported over 800 global pharmaceutical companies on more than 1500 drug molecules through our innovative technology and solid science in solid state research and formulation. We look forward to partnering with you together to accelerate your drug development and create a healthier world. https://www.crystalpharmatech.com/